Dissolution Methods for Long-acting Levonorgestrel Intrauterine System (U01)
The objective of this study is to investigate dissolution methods, both real time and accelerated conditions, for levonorgestrel intrauterine system (5-year application) and to analyze their capability of detecting manufacturing differences, predicting in vivo performance, and to evaluate method robustness. The results from this study will help the FDA in developing recommendations to determine bioequivalence of generic intrauterine systems. (Source: Grants.gov)
Source: Grants.gov - February 20, 2015 Category: Research Tags: Consumer Protection Food and Nutrition Health Source Type: funding

Dissolution Methods for Long-acting Levonorgestrel Intrauterine System (U01)
The objective of this study is to investigate dissolution methods, both real time and accelerated conditions, for levonorgestrel intrauterine system (5-year application) and to analyze their capability of detecting manufacturing differences, predicting in vivo performance, and to evaluate method robustness. The results from this study will help the FDA in developing recommendations to determine bioequivalence of generic intrauterine systems. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 13, 2015 Category: Research Source Type: funding